1119283-62-3

Basic information

• Product Name: (trans)-N,N-dibenzyl-4-(4-methylpiperazin-1-yl)cyclohexanamine
• Synonyms: (trans)-N,N-dibenzyl-4-(4-methylpiperazin-1-yl)cyclohexanamine
• CAS NO: 1119283-62-3
• Molecular Weight: 377.573
• Mol File: 1119283-62-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (trans)-N,N-dibenzyl-4-(4-methylpiperazin-1-yl)cyclohexanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (trans)-N,N-dibenzyl-4-(4-methylpiperazin-1-yl)cyclohexanamine(1119283-62-3)
• EPA Substance Registry System: (trans)-N,N-dibenzyl-4-(4-methylpiperazin-1-yl)cyclohexanamine(1119283-62-3)

Safety Data

• Hazardous Substances Data: 1119283-62-3(Hazardous Substances Data)

Upstream product

• 50910-54-8 trans-4-aminocyclohexanol hydrochloride 
• 149506-81-0 trans-4-(dibenzylamino)cyclohexanol 
• 100-39-0 benzyl bromide 
• 168893-04-7 N,N-dibenzyl-1,4-dioxaspiro[4.5]decan-8-amine 
• 131511-13-2 4-(N-benzylamino)cyclohexanone ethylene acetal 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 109-01-3 1-methyl-piperazine 
• 149506-79-6 4-(dibenzylamino)cyclohexanone 

Downstream Products

• 883195-08-2 (trans)-4-(4-methylpiperazin-1-yl)cyclohexanamine 
• 1280665-07-7 7-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[(trans)-4-(4-methylpiperazin-1-yl)cyclohexyl]-2,3-dihydrobenzofuran-4-carboxamide 
• 1280665-04-4 7-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-2,2-dimethyl-N-[(trans)-4-(4-methylpiperazin-1-yl)cyclohexyl]-3H-benzofuran-4-carboxamide 

Relevant articles and documents

DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF

Dihydroperidinone derivatives, preparation process and pharmaceutical use thereof are disclosed. Specially, new dihydroperidinone derivatives represented by general formula (I), wherein each substituent of the general formula (I) is defined as in the description, their preparation process, pharmaceutical compositions comprising said derivatives and their use as therapeutical agents, especially as Plk kinase inhibitors are disclosed.

NEW COMPOUNDS

Novel compounds of which the following is exemplary: